Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy
Clinical trial NCT02388984 · UNKNOWN
Trial details
- NCT number
- NCT02388984
- Sponsor
- Tasly Pharmaceuticals, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2017-05-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.